At Mylan Viatris, universal access to healthcare is an absolute priority. More than a simple objective, it is a global vision that guides every activity of the company. Today, Mylan Viatris is a key player in the pharmaceutical sector, reaching over1 billion patients worldwide, including 68 million in France, thanks to an unprecedented infrastructure and expertise. This mission is based on a fundamental principle: to offer high-quality healthcare solutions, accessible to all, and adapted to the varied needs of patients.
With its 450 molecules and over 1,500 product references, Mylan Viatris is today the leading pharmaceutical player in the French market by volume, a result that illustrates the impact and scope of its actions. With over 400 million boxes sold every year, every second in France, 12 patients benefit from a Mylan Viatris product. These figures reflect a clear commitment: to support patients throughout their treatment process, from diagnosis to prevention and treatment.
One of the strengths of Mylan Viatris is its industrial base in France. With two production and packaging sites located in the Lyon region, the brand supports French know-how and actively contributes to the local economy. These modern, innovative sites enable us to manufacture medicines that meet the most stringent quality and safety standards.
Beyond the infrastructure, it is the 1,350 Mylan Viatris employees who embody the brand's commitment on a daily basis. These professionals, experts in their respective fields, put their know-how at the service of patients, guaranteeing appropriate and effective healthcare solutions, whether for chronic illnesses, acute treatments or minor everyday ailments.
At Mylan Viatris, access to healthcare is not limited to the provision of medicines. The company is also committed to sustainable development, integrating environmentally-friendly practices into its operations. For example, on its production sites, a significant effort is made to reduce the ecological footprint: 75% to 89% of waste produced is recycled or recovered. This responsible approach is part of a broader vision, where public health and protection of the planet go hand in hand.
In addition, the brand carries out prevention and awareness-raising initiatives, such as the fight against hospital-acquired infections, and the improvement oftreatment compliance through adapted packaging. These programs, aimed at healthcare professionals and patients alike, reinforce Mylan Viatris' positive impact on the healthcare system.
Finally, Mylan Viatris collaborates with numerous associations to support essential causes. For over 15 years, it has been a partner of thePetits Princes association, which helps seriously ill children to make their dreams come true, and it plays an active part in the actions of the Tulipe association, dedicated to sending pharmaceutical products to crisis zones.
Innovation is at the heart of Mylan Viatris' strategy. The company not only produces high-quality generic medicines, but also seeks to develop integrated solutions to improve patient care. This includes tools for prevention, screening and treatment compliance, enabling comprehensive management of pathologies.
The Global Healthcare Gateway® is one of Mylan Viatris' flagship initiatives. This global network connects patients, healthcare professionals and commercial partners to cutting-edge medical solutions, reinforcing access to care on an international scale.
With an impressive range of products, Mylan Viatris has established itself as an essential leader in pharmaceuticals. Its range covers almost 100% of therapeutic areas, offering solutions adapted to a multitude of pathologies. Here are the main categories and their objectives:
This extensive coverage makes Mylan Viatris a trusted solution for patients and healthcare professionals alike.
When you choose Mylan Viatris, you're choosing more than just a drug. You're choosing a healthcare solution that combines quality, accessibility and sustainability. Each product is designed according to rigorous standards, with selected raw materials and regular checks to guarantee optimum efficacy.
Mylan Viatris does more than just produce medicines; it is also committed to improving prevention and patient care. With its varied ranges, awareness-raising initiatives and associative partnerships, the brand proves that it places people at the heart of its priorities.
Every year, generics produced by Mylan Viatris contribute to significant savings for national healthcare systems. These savings make it possible to finance medical innovation while maintaining universal access to treatments.
With initiatives ranging from local production to global programs, Mylan Viatris is acting for a healthier future. So why wait? Put your trust in a brand that combines innovation, expertise and human commitment.
